BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 11602692)

  • 1. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2001 Nov; 299(2):760-7. PubMed ID: 11602692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys.
    Negus SS; Gatch MB; Mello NK
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1123-36. PubMed ID: 9618415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar enhancement of the discriminative stimulus effects of cocaine and GBR 12909 by heroin in squirrel monkeys.
    Rowlett JK; Spealman RD; Platt DM
    Psychopharmacology (Berl); 2001 Sep; 157(3):313-9. PubMed ID: 11605088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms.
    Rowlett JK; Spealman RD; Platt DM
    Psychopharmacology (Berl); 2000 Jun; 150(2):191-9. PubMed ID: 10907672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the discriminative stimulus effects of buprenorphine in pigeons.
    Galici R; Brandt MR; France CP
    Psychopharmacology (Berl); 2002 Mar; 160(2):132-9. PubMed ID: 11875630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric generalization and interaction profiles in rhesus monkeys discriminating intravenous cocaine or intravenous heroin from vehicle.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2010 Mar; 332(3):985-95. PubMed ID: 19965959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1989 Sep; 250(3):937-43. PubMed ID: 2550623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
    Rowlett JK; Platt DM; Yao WD; Spealman RD
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone.
    Rowlett JK; Wilcox KM; Woolverton WL
    J Pharmacol Exp Ther; 1998 Jul; 286(1):61-9. PubMed ID: 9655842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.
    Negus SS; Gatch MB; Mello NK
    Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.
    Woods JH; Young AM; Herling S
    Fed Proc; 1982 Feb; 41(2):221-7. PubMed ID: 7037459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between mu and kappa receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1987 Nov; 243(2):591-7. PubMed ID: 2824753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ; Cook CD
    Behav Pharmacol; 1998 Jul; 9(4):319-28. PubMed ID: 10065920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.